Hosts
Top Stories from CNBC- China is not budging ahead of Xi-Trump G-20 meeting
- Trump calls India's tariff hike 'unacceptable,' demands its withdrawal
- Huawei says it's talking with Verizon and other US firms about royalties for using its patented tech
- 2020 Democratic candidates split on the biggest threats to the US
- Huawei says it doesn't cooperate with Chinese military — after report says its employees did
Health Care
Will the second half of the calendar year be a healthy one for health care stocks? Bertha Coombs reports.
The Trump Administration wants to make hospital and doctor fees public as part of its push to drive drive down costs. Bertha Coombs reports.
President Donald Trump will issue Monday an executive order designed to pressure insurers, doctors and other health-care providers to disclose more information about their prices, administration officials said.
The rise of health care cost is still a major issue for corporate America. A new survey shows that it may persists even longer. Bertha Coombs reports.
The presidential hopefuls aren’t the only ones eyeing health-care issues for 2020. Large employers are putting together benefit plans for next year, and they are expecting the rise in employee health costs to hit a four-year high, in part, due to rising drug prices.
A pharmacy warned the Food and Drug Administration that it found a chemical believed to cause cancer in a widely used blood pressure medication, according to a filing from the federal agency.
There’s a health care start-up that wants to shake up the complicated health care system. Bertha Coombs has the story for us.
Legal action may be brought to CVS on their recent $69 billion acquisition of Aetna. A federal judge could reportedly block the deal. Bertha Coombs has more for us.
Patients with private health insurance will soon be able to get HIV prevention medication, also known as pre-exposure prophylaxis or PrEP, at no cost after a recommendation from an influential health-care panel Tuesday.
Peloton, best known for its exercise cycles, announced Wednesday it has filed with securities regulators for an initial public offering.
The American Society of Clinical Oncology held a meeting in Chicago where they brought in over 40,000 doctors, researchers, and medical executives to discuss their latest fight in battling cancer.
The first landmark trial regarding opioid began on Tuesday where drug company, Johnson & Johnson, is facing a lawsuit in Oklahoma where they are accused of fueling that state’s opioid epidemic. Meg Tirrell has more for us.
Oklahoma state prosecutors blasted Johnson & Johnson and other opioid manufacturers in the first day of a landmark opioid trial Tuesday, saying they ran a “deceitful, multibillion-dollar brainwashing campaign” that led to more than 46,000 deaths in the state over a decade.
44 states have now filed a lawsuit accusing pharmaceutical companies of inflating generic drug prices. Meg Tirrell has more with this story.
There’s a new study that shows opioid prescriptions are on the decline and how the addiction epidemic is evolving. Meg Tirrell has more.
